Matthew Padley, from Hyde, Greater Manchester, was diagnosed with myeloma in 2023 after experiencing severe back pain which ...

Here is our Top Docs 2025 profile on Jeffrey Zonder, M.D., who is part of the Karmanos Cancer Institute’s Multiple Myeloma and Amyloidosis Multidisciplinary Team.

The increase in early-onset cancer incidence does not consistently indicate an increase in the occurrence of clinically ...

Last year, state epidemiologists studied an industrialized region east of Houston. They reported finding high rates of cancer ...

Collaboration between community practices and academic institutions is crucial for administering bispecific antibodies, with ...

Bouchard opened a discussion on sequencing therapies in MM, noting that CAR T-cell therapy and bispecific antibodies each ...

"This is what I had to do. My mother gave me my grandmother's silver, and I cashed it in to pay for my medical bills," ...

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and ...